Milestone Pharmaceuticals Inc. ($MIST)
Filing Information
| Accession Number | 0001437782-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Dec 12, 2025 |
| Document | View SEC Filing |
Transactions
6
Total Shares
860,777
Total Value
$375,314.67
P&L
+inf% (+$476,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Shares | โ | Dec 12, 2025 | Grant/Award | 280,000 | โ | โ | 583,721 | Direct | โ | View Details | |
Director | Common Shares | โ | Dec 15, 2025 | Sale | 133,054 | $2.32 | $308,685.28 | 450,667 | Direct | โ | View Details | |
Director | Common Shares | โ | Jan 26, 2026 | Exercise/Conversion | 66,600 | โ | โ | 517,267 | Direct | โ | View Details | |
Director | Common Shares | โ | Jan 26, 2026 | Sale | 34,523 | $1.93 | $66,629.39 | 482,744 | Direct | โ | View Details | |
Director | Employee Stock Option (right to buy) | Derivative | Dec 12, 2025 | Grant/Award | 280,000 | $0.00 | $0.00 | 280,000 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Jan 26, 2026 | Exercise/Conversion | 66,600 | $0.00 | $0.00 | 199,800 | Direct | โ | View Details |